Purpose Ultrahypofractionationed radiation therapy for prostate cancer is increasingly
studied and adopted. The American Association of Physicists in Medicine Working Group on …

Purpose Doses delivered to the urethra have been associated with an increased risk to
develop long-term urinary toxicity in patients undergoing stereotactic body radiotherapy …

Purpose Clinical trials assessing evaluation prostate stereotactic body radiation therapy
(SBRT) have used a wide range of allowed doses to the intraprostatic urethra, but the …

With over a decade׳ s worth of clinical experience to guide stereotactic body radiotherapy
(SBRT) for the treatment of clinically localized prostate cancer (PCa), sufficient data exist for …

Background To investigate whether the rate of stereotactic body radiation therapy-related
(SBRT-related) genitourinary (GU) toxicity is lower in patients with prostate cancer treated …

Purpose There is no evidence-based data to guide dose constraints in two-fraction prostate
stereotactic ablative radiotherapy (SABR). Using individual patient-data from two …

Purpose/objectives To report preliminary data on treatment outcome and compliance to
dose-intensified organ sparing SBRT for prostate cancer using a novel electromagnetic …

Purpose NCT03253744 was a phase 1 trial to identify the maximum tolerated dose (MTD) of
image-guided, focal, salvage stereotactic body radiation therapy (SBRT) for patients with …

Stereotactic body radiotherapy for prostate cancer is rapidly growing in popularity.
Stereotactic body radiotherapy plans mimic those of high-dose rate brachytherapy, with tight …

Stereotactic body radiotherapy (SBRT) is being increasingly utilized in the treatment of
prostate cancer. With the advent of high-precision radiosurgery systems, it is possible to …